What Cardiologists Should Know About Calcium Ion Channels and Their Regulation by Reactive Oxygen Species

Heart Lung and Circulation

Volumn 16, Issue 5, 2007, Pages 361-372

  Hool, Livia C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Calcium channels; Hypoxia; Mitochondria; Reactive oxygen species

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ANTIARRHYTHMIC AGENT; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; ION CHANNEL; ISOPRENALINE; NIFEDIPINE; PHENALKYLAMINE; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; THIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOLOGIST; CELL ACTIVITY; DRUG TARGETING; ELECTRIC ACTIVITY; HEART ARRHYTHMIA; HEART CONTRACTION; HEART EXCITATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HUMAN; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

CALCIUM CHANNELS; CARDIOLOGY; HEART DISEASES; HUMANS; MITOCHONDRIA; MYOCARDIUM; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES;

EID: 34848894264     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.01.005     Document Type: Review

References (142)

1. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., and Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
2. Ruwhof C., and van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 47 (2000) 23-37
3. Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis. A brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res Cardiol 93 (1998) 156-162
4. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 (1993) 118-126
5. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol 279 (2000) L1005-L1028
6. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003) 769-773
7. van Montfort R.L., Congreve M., Tisi D., Carr R., and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423 (2003) 773-777
8. 2+ currents in cardiac myocytes: Old story, new insights. Prog Biophys Mol Biol 91 (2006) 1-82
9. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., and Fox A.P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11 (1988) 431-438
10. Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., and Davidson N. Rat brain expresses a heterogeneous family of calcium channels. Proc Natl Acad Sci U S A 87 (1990) 3391-3395
11. Birnbaumer L., Campbell K.P., Catterall W.A., Harpold M.M., Hofmann F., Horne W.A., Mori Y., Schwartz A., Snutch T.P., Tanabe T., and Tsien R.W. The naming of voltage-gated calcium channels. Neuron 13 (1994) 505-506
12. Ertel E.A., Campbell K.P., Harpold M.M., Hofmann F., Mori Y., Perez-Reyes E., Schwartz A., Snutch T.P., Tanabe T., Birnbaumer L., Tsien R.W., and Catterall W.A. Nomenclature of voltage-gated calcium channels. Neuron 25 (2000) 533-535
13. Seisenberger C., Specht V., Welling A., Platzer J., Pfeifer A., Kuhbandner S., Striessnig J., Klugbauer N., Feil R., and Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem 275 (2000) 39193-39199
14. Zhang Z., Xu Y., Song H., Rodriguez J., Tuteja D., Namkung Y., Shin H.S., and Chiamvimonvat N. Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 90 (2002) 981-987
15. 2+ channels. Cell Physiol Biochem 14 (2004) 11-22
16. Munk A.A., Adjemian R.A., Zhao J., Ogbaghebriel A., and Shrier A. Electrophysiological properties of morphologically distinct cells isolated from the rabbit atrioventricular node. J Physiol 493 Pt 3 (1996) 801-818
17. 2+ currents in canine cardiac Purkinje cells. Am J Physiol 256 (1989) H1478-H1492
18. Takahashi M., Seagar M.J., Jones J.F., Reber B.F., and Catterall W.A. Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle. Proc Natl Acad Sci U S A 84 (1987) 5478-5482
19. Dolphin A.C. Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr 35 (2003) 599-620
20. Birnbaumer L., Qin N., Olcese R., Tareilus E., Platano D., Costantin J., and Stefani E. Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 30 (1998) 357-375
21. Foell J.D., Balijepalli R.C., Delisle B.P., Yunker A.M., Robia S.L., Walker J.W., McEnery M.W., January C.T., and Kamp T.J. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics 17 (2004) 183-200
22. Pragnell M., De Waard M., Mori Y., Tanabe T., Snutch T.P., and Campbell K.P. Calcium channel beta-subunit binds to a conserved motif in the I-II cytoplasmic linker of the alpha 1-subunit. Nature 368 (1994) 67-70
23. 2+ channels. J Biol Chem 270 (1995) 30036-30044
24. 2+ channel alpha1 subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit. Neuron 25 (2000) 177-190
25. 2+) channel beta subunits revealed by their expression in adult rat heart cells. J Physiol 541 (2002) 435-452
26. Hullin R., Khan I.F., Wirtz S., Mohacsi P., Varadi G., Schwartz A., and Herzig S. Cardiac L-type calcium channel beta-subunits expressed in human heart have differential effects on single channel characteristics. J Biol Chem 278 (2003) 21623-21630
27. Ellis S.B., Williams M.E., Ways N.R., Brenner R., Sharp A.H., Leung A.T., Campbell K.P., McKenna E., Koch W.J., Hui A., Schwartz A., and Harpold M.M. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science 241 (1988) 1661-1664
28. Qin N., Yagel S., Momplaisir M.L., Codd E.E., and D'Andrea M.R. Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit. Mol Pharmacol 62 (2002) 485-496
29. Klugbauer N., Lacinova L., Marais E., Hobom M., and Hofmann F. Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci 19 (1999) 684-691
30. Chu P.J., and Best P.M. Molecular cloning of calcium channel alpha(2)delta-subunits from rat atria and the differential regulation of their expression by IGF-1. J Mol Cell Cardiol 35 (2003) 207-215
31. 2+ channel alpha2delta subunit. J Neurosci 17 (1997) 6884-6891
32. Hansen J.P., Chen R.S., Larsen J.K., Chu P.J., Janes D.M., Weis K.E., and Best P.M. Calcium channel gamma6 subunits are unique modulators of low voltage-activated (Cav3.1) calcium current. J Mol Cell Cardiol 37 (2004) 1147-1158
33. Jay S.D., Ellis S.B., McCue A.F., Williams M.E., Vedvick T.S., Harpold M.M., and Campbell K.P. Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle. Science 248 (1990) 490-492
34. Singer D., Biel M., Lotan I., Flockerzi V., Hofmann F., and Dascal N. The roles of the subunits in the function of the calcium channel. Science 253 (1991) 1553-1557
35. Nakayama H., Wilkin B.J., Bodi I., and Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J 20 (2006) 1660-1670
36. Guinamard R., Demion M., Chatelier A., and Bois P. Calcium-activated nonselective cation channels in mammalian cardiomyocytes. Trends Cardiovasc Med 16 (2006) 245-250
37. Bush E.W., Hood D.B., Papst P.J., Chapo J.A., Minobe W., Bristow M.R., Olson E.N., and McKinsey T.A. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem 281 (2006) 33487-33496
38. 2+) channel mediating angiotensin II-induced myocardial apoptosis. Mol Cell Biochem (2006)
39. Fonfria E., Murdock P.R., Cusdin F.S., Benham C.D., Kelsell R.E., and McNulty S. Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res 26 (2006) 159-178
40. 2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ Res 96 (2005) 1274-1281
41. Fill M., and Copello J.A. Ryanodine receptor calcium release channels. Physiol Rev 82 (2002) 893-922
42. Lipp P., Laine M., Tovey S.C., Burrell K.M., Berridge M.J., Li W., and Bootman M.D. Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr Biol 10 (2000) 939-942
43. Khan A.A., Steiner J.P., Klein M.G., Schneider M.F., and Snyder S.H. IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science 257 (1992) 815-818
44. Leite M.F., Thrower E.C., Echevarria W., Koulen P., Hirata K., Bennett A.M., Ehrlich B.E., and Nathanson M.H. Nuclear and cytosolic calcium are regulated independently. Proc Natl Acad Sci U S A 100 (2003) 2975-2980
45. Bezprozvanny I., Watras J., and Ehrlich B.E. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351 (1991) 751-754
46. Lytton J., Westlin M., and Hanley M.R. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266 (1991) 17067-17071
47. Dipolo R., and Beauge L. Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions. Physiol Rev 86 (2006) 155-203
48. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 142 (2004) 231-255
49. Paky A., Michael J.R., Burke-Wolin T.M., Wolin M.S., and Gurtner G.H. Endogenous production of superoxide by rabbit lungs: effects of hypoxia or metabolic inhibitors. J Appl Physiol 74 (1993) 2868-2874
50. vanden Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273 (1998) 18092-18098
51. 2 gradients across biomembranes. FEBS Letters 475 (2000) 121-126
52. 2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors. Arch Biochem Biophys 154 (1973) 117-131
53. Stone J.R., and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8 (2006) 243-270
54. Bergamini C.M., Gambetti S., Dondi A., and Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Design 10 (2004) 1611-1626
55. Wolin M.S. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20 (2000) 1430-1442
56. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., and Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci U S A 88 (1991) 10045-10048
57. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., and Freeman B.A. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A 91 (1994) 1044-1048
58. Barford D. The role of cysteine residues as redox-sensitive regulatory switches. Curr Opin Struct Biol 14 (2004) 679-686
59. Andreyev A.Y., Kushnareva Y.E., and Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 70 (2005) 200-214
60. Bazan N.G., Palacios-Pelaez R., and Lukiw W.J. Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol 26 (2002) 283-298
61. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61 (2004) 461-470
62. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., and Epstein P.N. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53 (2004) 1336-1343
63. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18 (2000) 655-673
64. Pepe S. Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol 40 (2005) 751-758
65. Galle J., Quaschning T., Seibold S., and Wanner C. Endothelial dysfunction and inflammation: what is the link?. Kidney Int 84 (2003) S45-S49
66. Napoli C., Salomone S., Godfraind T., Palinski W., Capuzzi D.M., Palumbo G., D'Armiento F.P., Donzelli R., de Nigris F., Capizzi R.L., Mancini M., Gonnella J.S., and Bianchi A. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 30 (1999) 1907-1915
67. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
68. Ohtsubo T., Rovira I.I., Starost M.F., Liu C., and Finkel T. Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2. Circ Res 95 (2004) 1118-1124
69. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
70. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Investi 97 (1996) 1916-1923
71. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32 (1998) 488-495
72. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., Cave A.C., and Shah A.M. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93 (2003) 802-805
73. Li J.M., Gall N.P., Grieve D.J., Chen M., and Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
74. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
75. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol 552 (2003) 335-344
76. Turrens J.F. Superoxide production by the mitochondrial respiratory chain. Biosci Reports 17 (1997) 3-8
77. 2 production by membrane potential and NAD(P)H redox state. J Neurochem 86 (2003) 1101-1107
78. Korshunov S.S., Skulachev V.P., and Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416 (1997) 15-18
79. Campbell D.L., Stamler J.S., and Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108 (1996) 277-293
80. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
81. Gilbert H.F. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol Relat Areas Mol Biol 63 (1990) 69-172
82. 2+) current to beta-adrenergic receptor stimulation via a C2 region-containing protein kinase C isoform. Circ Res 87 (2000) 1164-1171
83. Yamaoka K., Yakehiro M., Yuki T., Fujii H., and Seyama I. Effect of sulfhydryl reagents on the regulatory system of the L-type Ca channel in frog ventricular myocytes. Pflugers Arch 440 (2000) 207-215
84. Lacampagne A., Duittoz A., Bolanos P., Peineau N., and Argibay J.A. Effect of sulfhydryl oxidation on ionic and gating currents associated with L-type calcium channels in isolated guinea-pig ventricular myocytes. Cardiovasc Res 30 (1995) 799-806
85. 2+ and Na+ channels. Circ Res 76 (1995) 325-334
86. 2+ channel alpha1C subunits by redox agents and hypoxia. J Physiol 514 (1999) 629-637
87. Zeng X.H., Xia X.M., and Lingle C.J. Redox-sensitive extracellular gates formed by auxiliary beta subunits of calcium-activated potassium channels. Nat Struct Biol 10 (2003) 448-454
88. Jeroudi M.O., Hartley C.J., and Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 73 (1994) 2B-7B
89. Sanguinetti M.C. When the KChIPs are down. Nat Med 8 (2002) 18-19
90. Keating M.T., and Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104 (2001) 569-580
91. Aon M.A., Cortassa S., Marban E., and O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 278 (2003) 44735-44744
92. Akar F.G., Aon M.A., Tomaselli G.F., and O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115 (2005) 3527-3535
93. 2+ channels on early after-depolarizations. Biophys J 88 (2005) 85-95
94. 2+ channel function during acute hypoxia. Cardiovasc Res 67 (2005) 624-635
95. 2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes. Circ Res 91 (2002) 601-609
96. 2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci U S A 96 (1999) 7944-7949
97. 2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol 475 (2000) 219-240
98. 2-sensing in model airway chemoreceptor cells. Biochem Biophys Res Comm 283 (2001) 1131-1134
99. 2+) channel activity by hypoxia in human and porcine coronary myocytes. Cardiovasc Res 53 (2002) 97-104
100. 2+) channel to alpha-adrenergic receptor stimulation in the presence of beta-adrenergic receptor stimulation. Circ Res 88 (2001) 1036-1043
101. 2+ concentration of myocytes isolated from different regions of the rat pulmonary arterial tree. Exper Physiol 83 (1998) 337-347
102. 2 inhibits calcium channel activity in arterial smooth muscle cells. Am J Physiol 271 (1996) H2290-H2299
103. 2+ channel. J Physiol 500 (1997) 551-556
104. 2+ channels. Circ Res 87 (2000) 537-539
105. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 79 (1999) 917-1017
106. McDonald T.F., Pelzer S., Trautwein W., and Pelzer D.J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 74 (1994) 365-507
107. Humphries K.M., Juliano C., and Taylor S.S. Regulation of cAMP-dependent protein kinase activity by glutathionylation. J Biol Chem 277 (2002) 43505-43511
108. Humphries K.M., Deal M.S., and Taylor S.S. Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J Biol Chem 280 (2005) 2750-2758
109. Brennan J.P., Bardswell S.C., Burgoyne J.R., Fuller W., Schroder E., Wait R., Begum S., Kentish J.C., and Eaton P. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 281 (2006) 21827-21836
110. 2+ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem Biophys Res Commun 318 (2004) 135-141
111. 2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production. Cardiovasc Res 69 (2006) 855-864
112. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287 (2004) C817-C833
113. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192 (2000) 1001-1014
114. Kaneko S., Kawakami S., Hara Y., Wakamori M., Itoh E., Minami T., Takada Y., Kume T., Katsuki H., Mori Y., and Akaike A. A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci 101 (2006) 66-76
115. McNulty S., and Fonfria E. The role of TRPM channels in cell death. Pflugers Arch 451 (2005) 235-242
116. Fonfria E., Marshall I.C., Boyfield I., Skaper S.D., Hughes J.P., Owen D.E., Zhang W., Miller B.A., Benham C.D., and McNulty S. Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem 95 (2005) 715-723
117. Kraft R., Grimm C., Grosse K., Hoffmann A., Sauerbruch S., Kettenmann H., Schultz G., and Harteneck C. Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol Cell Physiol 286 (2004) C129-C137
118. Kamsler A., and Segal M. Hydrogen peroxide modulation of synaptic plasticity. J Neurosci 23 (2003) 269-276
119. Poteser M., Graziani A., Rosker C., Eder P., Derler I., Kahr H., Zhu M.X., Romanin C., and Groschner K. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem 281 (2006) 13588-13595
120. Dulhunty A., Haarmann C., Green D., and Hart J. How many cysteine residues regulate ryanodine receptor channel activity?. Antioxid Redox Signal 2 (2000) 27-34
121. Sun J., Xu L., Eu J.P., Stamler J.S., and Meissner G. Classes of thiols that influence the activity of the skeletal muscle calcium release channel. J Biol Chem 276 (2001) 15625-15630
122. 2+ release from sarcoplasmic reticulum. Mol Cell Biochem 82 (1988) 81-84
123. 2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem 264 (1989) 21725-21736
124. Trimm J.L., Salama G., and Abramson J.J. Sulfhydryl oxidation induces rapid calcium release from sarcoplasmic reticulum vesicles. J Biol Chem 261 (1986) 16092-16098
125. Eu J.P., Xu L., Stamler J.S., and Meissner G. Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol 57 (1999) 1079-1084
126. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 (1998) 234-237
127. 2+ release channels. J Clin Invest 115 (2005) 2033-2038
128. Marban E., Robinson S.W., and Wier W.G. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. J Clin Invest 78 (1986) 1185-1192
129. 2+ release from vascular smooth muscle sarcoplasmic reticulum. Am J Physiol 262 (1992) H114-H116
130. 2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res 45 (2000) 397-409
131. 2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 103 (2001) 140-147
132. Napoli C., Sica V., Pignalosa O., and de Nigris F. New trends in anti-atherosclerotic agents. Curr Med Chem 12 (2005) 1755-1772
133. Schwartz C.J., Valente A.J., Sprague E.A., Kelley J.L., Cayatte A.J., and Mowery J. Atherosclerosis. Potential targets for stabilization and regression. Circulation 86 (1992) III117-III123
134. Pizzetti G., Mailhac A., Li Volsi L., Di Marco F., Lu C., Margonato A., and Chierchia S.L. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction. Ital Heart J 2 (2001) 757-765
135. Bestehorn H.P., Neumann F.J., Buttner H.J., Betz P., Sturzenhofecker P., von Hodenberg E., Verdun A., Levai L., Monassier J.P., and Roskamm H. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial. J Am Coll Cardiol 43 (2004) 2160-2165
136. Umemoto S., Tanaka M., Kawahara S., Kubo M., Umeji K., Hashimoto R., and Matsuzaki M. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 27 (2004) 877-885
137. Wang Q.D., Pernow J., Sjoquist P.O., and Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 55 (2002) 25-37
138. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104 (2001) 2981-2989
139. Glossmann H., Ferry D.R., Goll A., and Rombusch M. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. J Cardiovasc Pharmacol 6 Suppl. 4 (1984) S608-S621
140. Catterall W.A., Striessnig J., Snutch T.P., and Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol Rev 55 (2003) 579-581
141. Catterall W.A., Perez-Reyes E., Snutch T.P., and Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57 (2005) 411-425
142. Nerbonne J.M., and Kass R.S. Molecular physiology of cardiac repolarization. Physiol Rev 85 (2005) 1205-1253